MTOR and obesity due to melanocortin 4 receptor deficiency: Beyond the scope of this review are gestational diabetes [89], obesity treated with bariatric surgery [90,91] and the treatment of renal allograft recipients with mTOR inhibition who received the SARS-CoV-2 mRNA BNT 162 bz (Pfizer BioNTech) vaccine.